Compared with primary PCa cases (hormone-sensitive prostate cancer, HSPC), CRPC cases had a high prevalence of high or positive PD-L1 expression (OR = 6.01, 95% CI = 3.22-11.23, p < 0.001) (Figure 3). The gene discussed is CD274; the disease is posterior cortical atrophy.